🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
30.20
-2.34 (-7.19%)
Nov 20, 2026, 4:00 PM EST - Market closed

Nektar Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-177.26-164.08-118.96-276.06-368.2-523.84
Depreciation & Amortization
0.671.034.397.8213.0314.15
Loss (Gain) From Sale of Assets
---40.391.3-3.33-
Asset Writedown & Restructuring Costs
4.444.448.33111.8370.7116.7
Loss (Gain) on Equity Investments
48.73----
Stock-Based Compensation
12.6612.6521.6133.3957.3294.67
Other Operating Activities
-31.15-34.26-44.45-50.94-74.048.63
Change in Accounts Receivable
---3.054.7816.5112.4
Change in Inventory
--0.50.7-3.4-0.51
Change in Accounts Payable
2.57-0.632.67-2.883.1-11.69
Change in Other Net Operating Assets
-72.88-36.39-6.36-22.53-15.72-23.17
Operating Cash Flow
-256.96-208.51-175.71-192.61-304.01-412.66
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.23-0.87-1.47-0.87-5.68-14.99
Sale of Property, Plant & Equipment
---1.2513.2-
Investment in Securities
-682.1-0.3378.65139.18358.32217.77
Other Investing Activities
0.7-65.39---
Investing Cash Flow
-682.63-1.2142.57139.56365.84202.78

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-180.85----
Net Debt Issued (Repaid)
253.06180.85----
Issuance of Common Stock
6.040.870.120.030.7633.24
Repurchase of Common Stock
---3---
Other Financing Activities
674.14-1.1545-0.753
Financing Cash Flow
933.24180.5742.120.031.5136.24

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.01-00.06-0.33-0.09
Net Cash Flow
-6.35-29.148.98-52.9563.01-173.74

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-258.18-209.38-177.18-193.47-309.68-427.65
Free Cash Flow Growth
------
Free Cash Flow Margin
-494.74%-379.09%-180.01%-214.68%-336.41%-419.65%
Free Cash Flow Per Share
-9.19-12.41-12.92-15.27-24.82-35.00
Levered Free Cash Flow
-152.1-108.23-43.69-63.63-101.13-234.18
Unlevered Free Cash Flow
-132.3-91.86-26.12-47.8-83.06-204.61

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--0.20.082.660.270.33
Change in Working Capital
-70.31-37.02-6.24-19.940.49-22.97
SEC Filings: 10-K · 10-Q